You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.


A 73-Year-Old Man With CAD and Heart Failure

  • Authors: Kelley R. Branch, MD, MSc, FACC, FSCCT
  • CME / ABIM MOC Released: 5/5/2021
  • Valid for credit through: 5/5/2022
Start Activity

Target Audience and Goal Statement

This activity is intended for cardiologists, primary care physicians, and surgeons.

The goal of this activity is to review the use of optimal antithrombotic strategies in patients with coronary artery disease (CAD) and heart failure in an era of telemedicine visits.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Antithrombotic therapy to reduce cardiovascular (CV) risk in patients with CAD and comorbidities
  • Have greater competence related to
    • Use of evidence-based antithrombotic strategies to reduce CV risk in patients with CAD and comorbidities in an era of telemedicine visits


As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


  • Kelley R. Branch, MD, MSc, FACC, FSCCT

    Professor of Medicine
    University of Washington
    Cardiovascular Clinical Trials
    Associate Director
    Clinical Trials Service Unit
    Seattle, Washington


    Disclosure: Kelley R. Branch, MD, MSc, FACC, FSCCT, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Bayer, Janssen, Kestra, Sana
    Received grants for clinical research from: Bayer, Eli Lilly, Sanofi


  • Anne M. Sendaydiego, PharmD

    Medical Education Director, WebMD Global, LLC 


    Disclosure: Anne M. Sendaydiego, PharmD, has disclosed no relevant financial relationships

CME Reviewer

  • Esther Nyarko, PharmD

    Associate Director, Accreditation and Compliance, Medscape, LLC


    Disclosure: Esther Nyarko, PharmD, has disclosed no relevant financial relationships.

Medscape, LLC staff have disclosed that they have no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Abbott Labs

Accreditation Statements

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.


A 73-Year-Old Man With CAD and Heart Failure

Authors: Kelley R. Branch, MD, MSc, FACC, FSCCTFaculty and Disclosures

CME / ABIM MOC Released: 5/5/2021

Valid for credit through: 5/5/2022



Table. Zachary Barola's Current Clinical Data

 Age: 73


  • Coronary artery disease (CAD); coronary angiogram 4 years ago:
    • 40% mid-right coronary artery stenosis
    • 80% proximal left anterior descending (LAD) artery stenosis with small caliber vessel and luminal irregularities distally
    • 50% stenosis second obtuse marginal branch
    • Everolimus coated 2.75 x 15 mm stent placed in LAD with resolution of symptoms
  • Comorbidities: hypertension, hyperlipidemia, obesity
  • Previous smoker (20 pack-years; quit 10 years ago)

Clinical Data

  • Body mass index (BMI) = 30.5 kg/m2
  • Blood pressure (BP) = 138/90 mmHg
  • Low-density lipoprotein cholesterol (LDL-C) = 85 mg/dL

Current Rx

  • Aspirin 81 mg once daily
  • Atorvastatin 40 mg once daily
  • Lisinopril 40 mg once daily
  • Print